Diagnosis of Atrial Fibrillation in Postoperative Thoracic Surgery Using a Smartwatch
Centre Hospitalier Universitaire, Amiens
302 participants
Jun 1, 2025
INTERVENTIONAL
Conditions
Summary
Postoperative atrial fibrillation (POAF) occurs in approximately 20% of patients following thoracic surgery. Early diagnosis is essential to prevent complications such as heart failure, stroke, myocardial infarction, and increased mortality. Smartwatches equipped with single-lead ECG capabilities and algorithms to detect asymptomatic atrial fibrillation (AF) offer a potential solution. This study aims to evaluate the effectiveness of smartwatches in detecting POAF compared to standard care.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patients in the smartwatch group will undergo rhythm monitoring with a smartwatch
Detected POAF episodes will be confirmed via a 12-lead ECG
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06724718